Beta Bionics, Inc.(BBNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BBNX Beta Bionics, Inc.

Pre-Mkt 12-19 08:08:17 EST

29.06

-0.13

-0.45%

盘前29.59

+0.53+1.82%

07:03 EST

High30.64	Low28.83	Vol2.22M
Open30.05	D1 Closing29.19	Amplitude6.20%
Mkt Cap1.28B	Tradable Cap688.78M	Total Shares44.02M
T/O65.45M	T/O Rate9.35%	Tradable Shares23.70M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":29.06,"timestamp":1766091600000,"preClose":29.19,"halted":0,"volume":2216734,"hourTrading":{"tag":"盘前","latestPrice":29.59,"preClose":29.06,"latestTime":"07:03 EST","volume":157,"amount":4656.369899,"timestamp":1766145836696},"delay":0,"floatShares":23702000,"shares":44024631,"eps":-3.353704,"marketStatus":"Pre-Mkt","change":-0.13,"latestTime":"12-19 08:08:17 EST","open":30.05,"high":30.64,"low":28.83,"amount":65446284.915362,"amplitude":0.062008,"askPrice":31.39,"askSize":35,"bidPrice":25.84,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.353704,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766154600000},"marketStatusCode":1,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":29.06,"preHourTrading":{"tag":"盘前","latestPrice":29.59,"preClose":29.06,"latestTime":"07:03 EST","volume":157,"amount":4656.369899,"timestamp":1766145836696},"postHourTrading":{"tag":"盘后","latestPrice":29.1,"preClose":29.06,"latestTime":"18:25 EST","volume":434676,"amount":12631685.91,"timestamp":1766100312676},"volumeRatio":2.3059330236637483,"impliedVol":1.0003,"impliedVolPercentile":0.7692},"requestUrl":"/m/hq/s/BBNX/tweets","defaultTab":"tweets","newsList":[{"id":"2592904249","title":"Beta Bionics Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2592904249","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592904249?lang=en_us&edition=fundamental","pubTime":"2025-12-18 22:28","pubTimestamp":1766068080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 18, 2025 09:28 ET (14:28 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2592927648","title":"U.S. RESEARCH ROUNDUP-Autozone, Coursera, Lennar","url":"https://stock-news.laohu8.com/highlight/detail?id=2592927648","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592927648?lang=en_us&edition=fundamental","pubTime":"2025-12-18 14:42","pubTimestamp":1766040152,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Autozone, Coursera, LennarDec 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autozone, Courser","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nL4N3XO0FW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","ACHC","ARDT","CRL","ALB","BAC","CLW","LU1989763690.USD","ALL","DG","BBNX","CBT","CPT","LU0234570918.USD","CL","COUR","CMI","DOW","BK4090","BCAX","DAL","ACAD","AAL","CE","CF","ALSN","CLYM","DD","AXTA","SGXZ57979304.SGD","BTSG","BK4107","BRO","BSX","HOUS","SG9999001176.USD","BIIB","AMRZ","CTVA","AMAT","ASH","ACM","AVTX","BK4147","APD","AZO","CGNX","LU0345769631.USD","AJG","BK4548"],"gpt_icon":0},{"id":"2589358991","title":"Beta Bionics Inc. published an update to their financial calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2589358991","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589358991?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:45","pubTimestamp":1765197911,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. will pre-release its topline fourth quarter 2025 financial results the week of January 5, 2026. Members of the company's management team will host in-person meetings in San Francisco to discuss these results from January 12, 2026 through January 14, 2026. Investors can register for in-person meetings by contacting the company's investor relations representative at ir@betabionics.com.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via GlobeNewswire  on December 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDLbpcnhF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU0314104364.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014013.SGD","BBNX","LU2095319765.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4588","SG9999014039.USD","SG9999014005.SGD","NDAQ","LU2210149790.SGD","BK4585","SG9999014021.USD","BK4112"],"gpt_icon":0},{"id":"2589358724","title":"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2589358724","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589358724?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:45","pubTimestamp":1765197900,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Dec.  08, 2025  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/08/3201441/0/en/Beta-Bionics-to-Pre-Announce-Topline-Fourth-Quarter-2025-Financial-Results-the-Week-of-January-5-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBP","BBNX","BK4082"],"gpt_icon":0},{"id":"2588660930","title":"Beta Bionics Director Adam Lezack Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588660930","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588660930?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:20","pubTimestamp":1764710448,"startTime":"0","endTime":"0","summary":"Adam Lezack, a Director of Beta Bionics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL4ppwSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2588066098","title":"Beta Bionics Director Maria Palasis Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588066098","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588066098?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:20","pubTimestamp":1764710445,"startTime":"0","endTime":"0","summary":"Maria Palasis, Director at Beta Bionics Inc., reported a disposal of common shares of Beta Bionics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL9dXDRg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Beta Bionics Director Maria Palasis Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2581803380","title":"Beta Bionics Director Adam Lezack Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2581803380","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581803380?lang=en_us&edition=fundamental","pubTime":"2025-11-06 10:45","pubTimestamp":1762397144,"startTime":"0","endTime":"0","summary":"Adam Lezack, Director at Beta Bionics Inc., reported a disposal of common shares of Beta Bionics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDLbzwTgZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Beta Bionics Director Adam Lezack Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"1149357481","title":"Stock Track | Beta Bionics (BBNX) Soars 19.07% on Strong Q3 Results, Raised Guidance, and FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=1149357481","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149357481?lang=en_us&edition=fundamental","pubTime":"2025-10-29 22:40","pubTimestamp":1761748858,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics Inc. (NASDAQ: BBNX) are soaring 19.07% in pre-market trading on Wednesday following the company's impressive third-quarter 2025 financial results, raised full-year guidance,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"2579075849","title":"Truist Raises Price Target on Beta Bionics to $32 From $28, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2579075849","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579075849?lang=en_us&edition=fundamental","pubTime":"2025-10-29 21:47","pubTimestamp":1761745666,"startTime":"0","endTime":"0","summary":"Beta Bionics (BBNX) has an average rating of buy and mean price target of $30.20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2579904852","title":"Beta Bionics Price Target Raised to $32.00/Share From $26.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2579904852","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579904852?lang=en_us&edition=fundamental","pubTime":"2025-10-29 21:38","pubTimestamp":1761745080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 29, 2025 09:38 ET (13:38 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2579890379","title":"Truist Financial Keeps Their Buy Rating on Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579890379","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579890379?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:18","pubTimestamp":1761740307,"startTime":"0","endTime":"0","summary":"In a report released today, Richard Newitter from Truist Financial reiterated a Buy rating on Beta Bionics, Inc., with a price target of $32.00. Th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-keeps-their-buy-rating-on-beta-bionics-inc-bbnx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-keeps-their-buy-rating-on-beta-bionics-inc-bbnx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"1171810344","title":"Stock Track | Beta Bionics (BBNX) Soars 14.87% Pre-Market on Strong Q3 Results and Raised Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1171810344","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171810344?lang=en_us&edition=fundamental","pubTime":"2025-10-29 16:18","pubTimestamp":1761725922,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics Inc. (NASDAQ: BBNX) surged 14.87% in pre-market trading on Wednesday, October 29, 2025, following the company's impressive third-quarter earnings report and increased full-year...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"1177714766","title":"Stock Track | Beta Bionics (BBNX) Soars 14.87% Pre-Market on Strong Q3 Earnings, Raised Guidance, and FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=1177714766","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177714766?lang=en_us&edition=fundamental","pubTime":"2025-10-29 16:18","pubTimestamp":1761725921,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics Inc. (NASDAQ: BBNX) surged 14.87% in pre-market trading on Wednesday, following the company's impressive third-quarter 2025 financial results, raised full-year guidance, and a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"2579016926","title":"U.S. RESEARCH ROUNDUP-ATI, GoDaddy, Lyft","url":"https://stock-news.laohu8.com/highlight/detail?id=2579016926","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579016926?lang=en_us&edition=fundamental","pubTime":"2025-10-29 15:24","pubTimestamp":1761722665,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-ATI, GoDaddy, LyftOct 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including ATI, GoDaddy and Lyft, on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nL4N3WA0O8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","CURB","NTLA","CVLT","AOS","EFSC","FTAI","AWI","EW","IQV","BKNG","ESQ","FSBC","IVZ","HRI","AMT","INCY","AXTA","ET","WGS","DHI","LU1720051108.HKD","ENPH","BK4097","LU2413666004.HKD","ARQT","ABCB","BBNX","BMRC","LU0868494617.USD","LU1721427968.SGD","CAKE","BOH","RNA","BK4567","ARCC","CZR","GDDY","GLW","CLW","ATI","BK4512","CAC","DORM","CAR","CRS","ECL","BK4541","LU0882574055.USD"],"gpt_icon":1},{"id":"2579902942","title":"Beta Bionics Reports Strong Q3 Growth and Raises Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2579902942","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579902942?lang=en_us&edition=fundamental","pubTime":"2025-10-29 12:34","pubTimestamp":1761712466,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. ( ($BBNX) ) has released its Q3 earnings. Here is a breakdown of the information Beta Bionics, Inc. presented to its investors. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beta-bionics-reports-strong-q3-growth-and-raises-guidance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beta-bionics-reports-strong-q3-growth-and-raises-guidance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2579791385","title":"GUIDANCE: (BBNX) Beta Bionics Expects Full Year 2025 Revenue $96.5 Million, vs. FactSet Est of $91.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2579791385","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579791385?lang=en_us&edition=fundamental","pubTime":"2025-10-29 05:44","pubTimestamp":1761687874,"startTime":"0","endTime":"0","summary":"GUIDANCE: (BBNX) Beta Bionics Expects Full Year 2025 Revenue $96.5 Million, vs. FactSet Est of $91.4 Million","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2579868913","title":"Earnings Flash (BBNX) Beta Bionics Posts Q3 Loss $-0.33, vs. FactSet Est of $-0.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2579868913","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579868913?lang=en_us&edition=fundamental","pubTime":"2025-10-29 05:43","pubTimestamp":1761687827,"startTime":"0","endTime":"0","summary":"Earnings Flash (BBNX) Beta Bionics Posts Q3 Loss $-0.33, vs. FactSet Est of $-0.42","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"1170547490","title":"Stock Track | Beta Bionics (BBNX) Soars 19% After-Hours on Q3 Earnings Beat and Raised Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1170547490","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170547490?lang=en_us&edition=fundamental","pubTime":"2025-10-29 04:32","pubTimestamp":1761683545,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics Inc. (NASDAQ: BBNX) surged 19.44% in after-hours trading on Tuesday following the release of its third-quarter 2025 financial results, which exceeded analyst expectations and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"1199361653","title":"Stock Track | Beta Bionics Soars 19% After Hours on Strong Q3 Results and Raised Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1199361653","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199361653?lang=en_us&edition=fundamental","pubTime":"2025-10-29 04:32","pubTimestamp":1761683542,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics Inc. (NASDAQ: BBNX) surged 19.44% in after-hours trading on Tuesday following the release of the company's third-quarter 2025 financial results, which exceeded analyst...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"2579999600","title":"Beta Bionics Q3 EPS $(0.33) Beats $(0.44) Estimate, Sales $27.253M Beat $23.972M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2579999600","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579999600?lang=en_us&edition=fundamental","pubTime":"2025-10-29 04:02","pubTimestamp":1761681771,"startTime":"0","endTime":"0","summary":"Beta Bionics (NASDAQ:BBNX) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.44) by 24.31 percent. This is a 77.4 percent increase over losses of $(1.46) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/10/48478158/beta-bionics-q3-eps-0-33-beats-0-44-estimate-sales-27-253m-beat-23-972m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Beta Bionics Q3 EPS $(0.33) Beats $(0.44) Estimate, Sales $27.253M Beat $23.972M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.betabionics.com","stockEarnings":[{"period":"1week","weight":-0.0085},{"period":"1month","weight":0.0719},{"period":"3month","weight":0.2939},{"period":"6month","weight":0.6244},{"period":"1year","weight":0.7094},{"period":"ytd","weight":0.7094}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Beta Bionics, Inc.","nameEN":"Beta Bionics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beta Bionics, Inc.(BBNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Beta Bionics, Inc.(BBNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Beta Bionics, Inc.,BBNX,Beta Bionics, Inc.股票,Beta Bionics, Inc.股票老虎,Beta Bionics, Inc.股票老虎国际,Beta Bionics, Inc.行情,Beta Bionics, Inc.股票行情,Beta Bionics, Inc.股价,Beta Bionics, Inc.股市,Beta Bionics, Inc.股票价格,Beta Bionics, Inc.股票交易,Beta Bionics, Inc.股票购买,Beta Bionics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beta Bionics, Inc.(BBNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Beta Bionics, Inc.(BBNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}